In Investing

RAD 202 receives approval to start Phase 1 therapeutic trial

Radiopharm Theranostics (RAD:AU) has announced RAD 202 receives approval to start Phase 1 therapeutic trial

Download the PDF here.

This post appeared first on investingnews.com

Author

We appreciate you signing up! You’re now part of our community and will be the first to receive our latest updates, exclusive offers, and special content. Stay tuned for exciting news and insights straight to your inbox.
Your name

Your email
By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.
Popular News
- In Editor's Pick
  Trump fills latest Cabinet spots as Jan. 20 inauguration nears
  January 11, 2025 No Comments
- In Latest News
  Vince McMahon settles with SEC over hush money agreements as civil assault case continues
  January 11, 2025 No Comments

Trump fills latest Cabinet spots as Jan. 20 inauguration nears